tiprankstipranks
Trending News
More News >
Sun Pharmaceutical Industries Limited (IN:SUNPHARMA)
:SUNPHARMA
India Market

Sun Pharmaceutical Industries Limited (SUNPHARMA) Income Statement

Compare
3 Followers

Sun Pharmaceutical Industries Limited Income Statement

Last quarter (Q4 2025), Sun Pharmaceutical Industries Limited's total revenue was ₹129.59B, an increase of 8.14% from the same quarter last year. In Q4, Sun Pharmaceutical Industries Limited's net income was ₹21.50B. See Sun Pharmaceutical Industries Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 525.78B₹ 477.58B₹ 432.79B₹ 384.26B₹ 331.39B
Gross Profit
₹ 292.83B₹ 229.46B₹ 326.17B₹ 267.19B₹ 232.54B
Operating Expenses
₹ 131.27B₹ 126.30B₹ 233.73B₹ 182.42B₹ 168.36B
Depreciation and Amortization
₹ 25.75B₹ 25.57B₹ 25.29B₹ 21.44B₹ 20.80B
EBITDA
₹ 150.86B₹ 138.36B₹ 120.85B₹ 67.00B₹ 49.99B
Operating Income
₹ 125.11B₹ 104.68B₹ 93.05B₹ 81.47B₹ 64.28B
Other Income/Expenses
₹ 12.41B₹ 6.20B₹ -124.96B₹ -36.44B₹ -36.99B
Pretax Income
₹ 137.37B₹ 110.88B₹ 94.08B₹ 44.81B₹ 27.99B
Net Income
₹ 109.29B₹ 95.76B₹ 84.74B₹ 32.73B₹ 29.04B
Per Share Metrics
Basic EPS
₹ 45.60₹ 39.91₹ 35.32₹ 13.64₹ 12.10
Diluted EPS
₹ 45.60₹ 39.91₹ 35.32₹ 13.64₹ 12.10
Weighted Average Shares Outstanding
2.40B 2.40B 2.40B 2.40B 2.40B
Weighted Average Shares Outstanding (Diluted)
2.40B 2.40B 2.40B 2.40B 2.40B
Currency in INR

Sun Pharmaceutical Industries Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis